Stockreport

Roivant Sciences: Booming Pipeline Without Product Revenues Creates Valuation Riddle [Seeking Alpha]

Roivant Sciences Ltd.  (ROIV) 
PDF My previous 'Hold' rating reflected both optimism for catalysts and caution about valuation and execution risks. The company remains a 'fiercely economic actor' with [Read more]